18/05/2026
Hypertension remains a leading risk factor for cardiovascular diseases, often progressing silently without noticeable symptoms. At the National Institute for Pharmaceutical Research and Development (NIPRD), we are committed to advancing research, innovation, and evidence-based solutions to support prevention, early detection, and effective management.